US Patent 8846618 Stable formulation of modified GLP-1
Patent 8846618 was granted and assigned to Novo Nordisk on September, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8846618 Stable formulation of modified GLP-1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
